Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,180.00
Bid: 1,176.00
Ask: 1,188.00
Change: 12.00 (1.03%)
Spread: 12.00 (1.02%)
Open: 1,170.00
High: 1,210.00
Low: 1,170.00
Prev. Close: 1,168.00
AVON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Restatement of FY22 Results

13 Oct 2023 07:00

RNS Number : 9980P
Avon Protection PLC
13 October 2023

13 October 2023

Avon Protection plc

("Avon Protection" or "the Group")

Full Year Trading Update and Restatement of Prior Year Financial Results to Reflect New Segmentation

"Full year performance in line with expectations, with a stronger H2 reflecting good strategic progress"

Avon Protection announces a trading update for the financial year ended 30 September 2023 ("FY 2023") ahead of the publication of its Year End Results on 21 November 2023.

Full year trading in line with the Board's expectations

As expected, trading in the second half of 2023 was stronger than in the first half, with order book growth and higher underlying earnings.

The order book as at 30 September 2023 showed growth of over 10% compared to the prior year, with strong demand for helmets offsetting expected softness in Respiratory demand. We now have $59m of outstanding orders for Next Generation Integrated Head Protection System ("NG IHPS") helmets and have recently received a further delivery order valued at over $7m for the Advanced Combat Helmet GEN II ("ACH GEN II"), bringing total outstanding orders for this helmet to over $20m.

As expected, revenue excluding armour in the second half was significantly above the first half, driven by the successful ramp up of the NG IHPS programme, encouraging sales of the new EPIC range of helmets and shipment of a previously announced large mask order.

H2 adjusted operating profit margin is broadly flat versus H1, with some early benefits from the strengthen and transform initiatives within our STAR strategy offsetting the mix effect of strong growth in the lower margin Head Protection business.

Net debt:EBITDA on a covenant basis at the end of FY 2023 is expected to have reduced to around 2.0 times, compared to 2.6 times at the end of H1 2023. This improvement is the result of our successful exit from the Armour business and the improved profitability in the second half of the year.

The year end net debt position on a covenant basis is now expected to be approximately $65m, as a result of the timing of cash receipts from the shipment of several large orders in the last month of the financial year. We expect the receivables associated with these orders to be paid during the first quarter of the 2024 financial year, which will further reduce net debt by up to $20m.

Good strategic and operational progress with our STAR strategy

The Group has continued to make good progress with the STAR strategy set out at the time of the Half Year Results. In particular, significant progress has been made in the detailed planning of the STAR strategic initiatives, which has confirmed that there is an excellent opportunity to grow the top line, improve margins and deliver strong cash generation and attractive returns on capital.

More broadly, there are several key proof points that have been achieved during the second half which speak to the Group's strategic progress and operational improvement.

· All outstanding armour products have now been delivered to our customers, and we therefore expect the Armour business to be classified as discontinued for FY 2023. This means that we now have a more profitable and focused business and a stronger platform for future growth.

· We have delivered over 10,000 NG IHPS helmets to the customer in line with our plan for H2 2023, with our initiatives to strengthen the Irvine and Salem plants resulting in significantly more reliable operational performance.

· We have received a further delivery order for the ACH GEN II helmet valued at over $7m, illustrating the DOD's confidence in our ability to deliver that programme.

· Following the launch of the EPIC helmet for the commercial market in H2 2023, we have received orders for over 5,500 helmets and have shipped 3,200 with good levels of productivity.

Jos Sclater, CEO of Avon Protection, commented:

"We are now seeing more reliable financial performance as a result of our actions to strengthen the business by increasing accountability and improving operations and programme management. In particular, we have demonstrated our ability to deliver helmets to the DOD, which is reflected by a stronger order book. Our focus is now turning to our multi-year plan to improve margins through the transform pillar of our STAR strategy. I am delighted to see the Avon team rising to the challenge of realising our full potential and remain excited by the significant opportunity to expand cash-backed margins, accelerate growth and improve return on capital."

Prior year comparators

At the Half Year Results, we announced a new operating model for the Group, with the creation of two Strategic Business Units (SBUs): Respiratory Protection and Head Protection. The implementation of this structure is now complete, with both SBUs fully resourced and internal performance management and reporting structures in place.

Our FY 2023 financial results will reflect the new organisational design, and prior year comparators are therefore provided below demonstrating FY 2022 financial results under the new segmental structure.

FY 2022 and H1 2023 Group and segmental performance

FY 2022

H1 2023

$m

Respiratory Protection

Head Protection

Adjusted total*

Respiratory Protection

Head Protection

Adjusted total*

Revenue

193.0

70.5

263.5

68.5

33.1

101.6

Adjusted EBITDA

42.4

(3.6)

38.8

17.5

(1.6)

15.9

Adjusted depreciation, amortisation and impairment

(8.9)

(6.5)

(15.4)

(3.9)

(3.1)

(7.0)

Adjusted operating profit/(loss)

33.5

(10.1)

23.4

13.6

(4.7)

8.9

*Adjusted total excluding Armour as previously disclosed in note 2.1, page 136 of the Group's 2022 Annual Report and Accounts.

For further enquiries, please contact:

Avon Protection plc

Jos Sclater, Chief Executive Officer

+44 1225 896 848

Rich Cashin, Chief Financial Officer

Rory Wiltshire, Investor Relations Manager

MHP

Tim Rowntree

+44 7817 458804

Ollie Hoare

avonprotection@mhpgroup.com

Legal Entity Identifier: 213800JM1AN62REBWA71

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

About Avon Protection:

Avon Protection make products that are trusted to protect the world's militaries and first responders.

Our dedicated teams achieve this by developing mission-critical solutions that enhance our customers' performance, efficiency and capability, whilst providing ever-increasing levels of protection.

With a portfolio that includes respiratory and head protection systems, we are renowned for our innovative thinking and our steadfast approach to manufacturing unrivalled products.

For further information, please visit our website www.avon-protection-plc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFFLESEEDSEDS
Date   Source Headline
18th Apr 20241:00 pmRNSHolding(s) in Company
8th Apr 202411:00 amRNSDirectors'/PDMR Shareholdings
5th Apr 20247:00 amRNSHolding(s) in Company
25th Mar 20244:30 pmRNSDirector/PDMR Shareholding
14th Mar 20249:17 amRNSAppointment of Non-Executive Director
6th Mar 20244:17 pmRNSDirectors'/PDMR Shareholdings
20th Feb 20245:00 pmRNSFinal Dividend Currency Exchange Rate
13th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20247:00 amRNSCapital Markets Event
6th Feb 202410:00 amRNSDirectors'/PDMR Shareholdings
5th Feb 20247:00 amRNSNext Generation IHPS Delivery Order
30th Jan 20241:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:00 pmRNSResult of AGM
26th Jan 20247:00 amRNSAGM Trading Update
25th Jan 20243:00 pmRNSPDMR Shareholdings
24th Jan 20247:00 amRNSU.S. Defense Logistics Agency helmet order
15th Jan 20247:00 amRNSGerman Navy underwater rebreather contract
11th Jan 20244:00 pmRNSDirectors'/PDMR Shareholdings
4th Jan 20247:00 amRNSNotice of Capital Markets Event
21st Dec 20233:00 pmRNSHolding(s) in Company
14th Dec 202310:00 amRNSPDMRs’ Interest in Shares
12th Dec 20233:00 pmRNSNotice of Annual Report, Accounts and 2024 AGM
7th Dec 20239:28 amRNSDirector/PDMR Shareholding
27th Nov 20239:00 amRNSHolding(s) in Company
23rd Nov 20236:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSPreliminary Results
7th Nov 20234:00 pmRNSDirector/PDMR Shareholding
20th Oct 20233:00 pmRNSNotification of PDMR Dealing
20th Oct 20231:00 pmRNSDirector/PDMR Shareholding
18th Oct 20236:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
13th Oct 20237:00 amRNSTrading Update & Restatement of FY22 Results
6th Oct 20231:00 pmRNSDirectors'/PDMR Shareholdings
21st Aug 20233:00 pmRNSInterim Dividend Currency Exchange Rate
8th Aug 20231:00 pmRNSDirector/PDMR Shareholding
25th Jul 20232:00 pmRNSHolding(s) in Company
19th Jul 20234:00 pmRNSHolding(s) in Company
14th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 20238:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSU.S. Army Next-Generation Ballistic Helmet Order
27th Jun 20235:00 pmRNSHolding(s) in Company
20th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:00 pmRNSHolding(s) in Company
6th Jun 20232:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20235:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.